二吲哚甲烷 Diindolylmethane (DIM) × 痤瘡

結論:台灣市場資訊黑箱

DIM 用於痤瘡的人體療效證據實質為零:L2 PubMed 2020-2026 找不到任何 RCT、SR 或 MA 直接評估 DIM 治療 acne,僅有 1 篇體外 C.

C 🟠 C 薄弱證據 台灣法規禁言 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 💊 檢驗 / 藥物交互作用

DIM 用於痤瘡的人體療效證據實質為零:L2 PubMed 2020-2026 找不到任何 RCT、SR 或 MA 直接評估 DIM 治療 acne,僅有 1 篇體外 C. acnes biofilm 抑制(Kim 2022)+ 兩篇估雌激素代謝調節人體研究(其中 Newman 2024 有 Precision Analytical 業界 COI),加上一篇前列腺癌細胞 AR 拮抗的體外機轉文(Le 2003)。

坊間廣傳的『12 週 30% 發炎性病灶減少』完全無 PubMed-indexed 一手來源可追溯。

L5b/L5c/L5d/L5e 四大主流權威(Mayo、Cleveland、Harvard、AAD)對 DIM-for-acne 一致 not_addressed;尤其 AAD 2024 痤瘡指引 CAM 章節明列 zinc/tea tree/brewer's yeast/green tea/低 GI 飲食卻完全跳過 DIM,這比 zinc 的『no recommendation』還弱──連被納入文獻回顧的門檻都沒到。

據 Tier 錨點,此情境符合『U(未驗證):無可靠人體研究』。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.44
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 台灣法規禁言
信心度
77%
證據方向大致一致
證據層級
E7
單篇小型隨機對照試驗

各層「支持此療效」的程度

分數越低=該層越不支持
L11 AI 複核獨立判讀
0.20
L2 PubMed原始文獻
0.40
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.50
L5 臨床機構權威立場
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.44
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

DIM Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and C. albicans
PMID: 35107361 2022 Cross-sectional
結論:DIM at 0.1 mM significantly inhibited planktonic growth and biofilm formation by C. acnes (P<0.05); also blocked S. aureus + C. albicans co-biofilm and downregulated biofilm-related genes (lipase, hyaluronate lyase).
🟠 品質有限 學術資助
前往 PubMed
Impact of DIM on urinary estrogen profile of premenopausal women
PMID: 39578798 2024 Cohort n = 909
結論:DIM users showed significant differences in nearly all urinary estrogen metabolites (P<0.001) vs non-users; 2-OHE1:16-OHE1 ratio significantly increased in both whole-group and pre/post analyses, consistent with shift toward less-estrogenic metabolism. No acne or skin endpoint measured.
🟠 品質有限 ⚠️ 廠商資助
前往 PubMed
DIM modulates estrogen metabolism in thyroid proliferative disease patients
PMID: 21254914 2011 RCT (open-label)
結論:2-OHE1:16-OHE1 ratio significantly increased (P<0.05), consistent with antiestrogenic activity. No skin/acne endpoints.
🟠 品質有限 政府資助
前往 PubMed
DIM is a strong androgen receptor antagonist in human prostate cancer cells
PMID: 12665522 2003 Cross-sectional
結論:DIM is a strong competitive inhibitor of DHT-AR binding; blocks AR nuclear translocation and PSA transcription; functions as bifunctional hormone disrupter.
🟠 品質有限 政府資助
前往 PubMed

L4a US FDA
謹慎
3,3'-DIINDOLYLMETHANE 來源↗
L4b EU EFSA
反對
Purified, synthetic 3,3'-diindolylmethane powder in supplement form is considered novel... 3,3'-diindolylmethane powder has been classified as a 'Novel Food' because it had not been consumed to a significant degree by humans in the UK or the European Union before May 15, 1997. It has not been granted authorization for sale as a food supplement. 來源↗
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
未表態
— 本適應症無對應資料
L4e WHO
支持
3,3'-Diindolylmethane (DIM). CAS 1968-05-4. Source materials: Brassica oleracea var. botrytis (cauliflower), var. capitata (cabbage), var. gemmifera (Brussels sprouts), var. italica (broccoli) — whole plant. Schedule 1, Item 2 (isolate). Approved Use(s) or Purpose(s): Source of/Provides antioxidants that help fight/protect cells against/reduce the oxidative effects of (or oxidative damage cause… 來源↗

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態
— 本適應症無對應資料

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣 PTT/Dcard/Mobile01 幾乎無針對二吲哚甲烷(DIM)抗痘的真實鄉民討論。中文可見內容多為單一代理電商部落格(姬菈原生 Estroblock)業配、iHerb/BigGo 購物頁與中國知乎/百度科普,缺乏匿名社群實測辯證,屬冷門保健品。

💬社群實感

無共識(台灣社群幾乎無真實實測討論)

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

DIM,二吲哚甲烷,100毫克,120片

代表來源 ↗
L10b · TFDA 法定身份 官方認定

尚未獲得台灣TFDA核准作為任何疾病之治療藥物

來源 ↗

  • 外用 A 酸(類視黃醇)
  • 過氧化苯(BPO)
  • 口服 isotretinoin(口服 A 酸)
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v6 engine_version: v1.0 claim_id: CLM-COND-acne-INT-diindolylmethane-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-acne-INT-diindolylmethane-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "二吲哚甲烷能改善痤瘡",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}